G3T is a pre-clinical stage biotechnology company developing novel therapeutic approaches for serious diseases that cause significant individual suffering and societal burden.

We are an innovative biopharmaceutical company, trailblazing the use of deep, panomic biological big data for drug discovery and development.

We are developing revolationary therapeutics enabled by our own, prospectively collected, deep biological big data, analyzed through visionary machine learning (ML) and artificial intelligence (AI) approaches.